Psychosocial and Medication Treatment for Anxiety in Alcoholism
CBT And Venlafaxine Treatments For Anxiety In Alcoholism
Sponsor: Boston Medical Center
Listed as NCT00248612, this PHASE2/PHASE3 trial focuses on Alcohol-Related Disorders and Anxiety Disorders and remains completed. Sponsored by Boston Medical Center, it has been updated 11 times since 2003, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2_PHASE3
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE2_PHASE3
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
-
Sep 2017 — Oct 2017 [monthly]
Completed PHASE2_PHASE3
-
Feb 2017 — Sep 2017 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2_PHASE3
First recorded
Sep 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Medical Center
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
For direct contact, visit the study record on ClinicalTrials.gov .